General MedicationsTOPICALGeneric
LOCORTEN
FLUMETHASONE PIVALATE
Standard Dose
0.03%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview LOCORTEN is listed in Drugs@FDA under application 016379 (NDA).
Marketing status: Discontinued Active ingredient FLUMETHASONE PIVALATE Form and strength CREAM;TOPICAL - 0.03% Sponsor NOVARTIS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview LOCORTEN is listed in Drugs@FDA under application 016379 (NDA). Marketing status: Discontinued Active ingredient FLUMETHASONE PIVALATE Form and strength CREAM;TOPICAL - 0.03% Sponsor NOVARTIS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.